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Introduction 
After the human genome project yielded the discovery of only 20,000 protein coding 
genes, research on the microbiota, the microorganisms found in and on humans, have grown. In 
particular, the gut microbiota, which outnumbers human’s cells by 10 times, is a recent topic of 
interest [1]. By looking at the greater abundance of microbes, researchers theorized that the 
interaction of human genes with this greater population leads to complex human life [1, 2]. To 
understand the nature of human diversity and disease, we must study the microbes that are so 
prevalent. 
Studies have shown long-term dietary intake influences the human gut microbiome [3]. A 
study on 18 people found that by comparing 4 days of their diet by total protein, carbohydrate, 
and insoluble fiber intake, the structure and function of their gut microbiome was significantly 
associated with dietary intake [4]. Different diets as well, such as switching from a low-fat diet to 
a high-fat, high-sugar “Western” diet changed the microbiota and its gene expression [5]. The 
biochemical mechanisms behind these changes are just beginning to be understood. Studies have 
shown that gut microbiota extract nutrients and energy from the diet and play a role in gut health 
and disease through production of metabolites and maintenance of gut integrity [6, 7]. The 
Bacteroidetes phyla, for example, have been shown to include bacteria that have several 
carbohydrate utilization pathways [8]. Decreasing nutrients in a diet produces measurable 
differences in gut microbes that are associated with increased energy production, showing how a 
human’s deficiencies can lead to greater microbiota dependence [5]. There is a give and take 
relationship between microbiota composition and diet that drives gut health and metabolism. 
 Understanding these processes is critical because as microbiota changes, it affects health 
outcomes. An experiment on humanized mice found switching from a standard low-fat, plant 
polysaccharide-rich diet to a Western diet changed fecal microbiomes within a day [7]. By 
transplanting Western diet mice’s microbiota into previously normal mice, the lean germ-free 
mice gained a greater fat disposition characteristic within 2 weeks [7]. In addition to obesity, the 
gut microbiome has been implicated in the pathways to circulatory disease [9], autism [10], and 
diabetes [11]. Inflammation in metabolic processes has been shown to lead to metabolic 
syndrome, obesity and diabetes [8]. Indeed, it has been hypothesized that bacterial 
lipopolysaccharides from gram-negative bacteria within the Bacteroidetes and Proteobacteria 
phyla may be the trigger for this inflammation [12]. 
Given that altering specific groups of gut microbiota is associated with obesity and 
diabetes, identifying phyla associated with certain diseases is being explored. The mechanisms 
proposed linking gut microbiota to obesity and diabetes through chronic endotoxinemia [12] and 
modulation of gut-derived peptide secretion [13] suggest Bacteroidetes, Firmicutes, 
Proteobacteria, and Actinobacteria as possible targets.  This is important to consider because 
Frank et al. found that the majority of gut bacteria were associated within those four phyla of 
bacteria [14]. These mechanisms from changes in gut microbiota are still being explored in both 
type 1 and type 2 diabetes. A study on type 1 diabetes in children found that the abundances of 
Actinobacteria, Firmicutes, and Bacteroidetes were significantly different between healthy and 
diabetic children, but Proteobacteria and Fusobacteria were similar between the groups [15]. A 
separate study on type 2 diabetes in human adults found that the abundance of Firmicutes was 
lower while Bacteroidetes and Proteobacteria were higher in diabetic adults than in nondiabetic 
adults [16]. This also means that the ratio of Bacteroidetes to Firmicutes correlated positively with 
plasma glucose but not with BMI. This could indicate that obesity and diabetes are associated 
with different groups of gut microbiota [17]. Other studies have found contrasting results for 
Proteobacteria; one showing a negative correlation between abundance and diabetic phenotype 
against the finding of high abundance of Proteobacteria in patients with metabolic diseases [16,18]. 
Although these phyla of bacteria, Firmicutes, Bacteroidetes, Proteobacteria, and 
Actinobacteria have been studied with relation to diabetes, how microbiota vary in populations 
experiencing rapid urbanization is now well studied. Transitioning from traditional rural to 
Westernized urban lifestyles is associated with altered diet, decrease in physical activity, and 
increased risk of diseases [19]. How the gut microbiota changes and how this affects disease risk 
is still being explored. Increasing knowledge of how urbanization in China associates with 
differences in the microbiome by contrasting urban and rural individuals living in similar regions 
may be informative since previous studies have made such contrasts across different countries 
and regions. The objective of this study is to examine how glycemic status is associated with 
differences in the bacteria abundance in a similar region of southern China while thinking about 
what role rural/urban status plays. Using linear regression, the Firmicutes, Bacteroidetes, 
Proteobacteria, and Actinobacteria abundances in individuals with elevated versus normal 
HbA1c was examined. 
 
Methods  
Participants 
This analysis includes twenty urban subjects from a city and twenty people from a rural 
village in Hunan Province (Southern China). Individuals were aged 18-65 years and were 
excluded if they had lived in those communities for less than 2 years, had been diagnosed with 
cancer, reported antibiotic use in the past three months, or were pregnant or lactating at the time 
of the exam.  
Data Collection 
China CDC data collectors recorded participant characteristics during 3 day house visit 
and collected fecal samples. Sequencing of microbiome was performed by the Beijing Genomics 
Institue-Shenzhen, using an Illumina MiSeq PE250 for 16S rRNA sequencing targeting the V4 
hypervariable region. 16S rRNA sequencing reads were then classified using the Ribosomal 
Database Project classifier. Sequencing was completed using fecal samples collected at two time 
points, separated by two weeks. This was a UNC IRB approved study for data collection and 
analysis of microbiome and phenotypic data [20]. 
Data Analysis 
 All data analysis was completed using STATA version 14 (StataCorp). Significant 
differences in the urban versus rural participants were quantified. Contrasting individuals with 
normal (<5.7%) versus elevated (≥5.7%) HbA1c levels were similarly found. A linear regression 
was used to estimate differences in phyla Firmicutes, Bacteroidetes, Proteobacteria, 
Actinobacteria, and the ratio between Firmicutes and Bacteroidetes (log transformed normalized 
to examine linear trends). Statistical testing used Wilcoxon signed-rank test because data were 
assumed not to be normally distributed. Interaction terms between normal/elevated HbA1c and 
rural/urban status were included in the models and estimates were visually examined using 
Stata’s margins confidence interval plots to test for effect measure modification. The potential 
for confounding was assessed by comparing estimates before and after covariable adjustment for 
rural/urban status: a change-of-estimate greater than 10% was considered evidence of 
meaningful confounding. 
Results 
Sociodemographic 
Sociodemographic characteristics for all 40 participants in the study by rural and urban 
status are shown in Table 1. Urban subjects had statistically significantly greater insulin, waist 
circumference, BMI, and HbA1c levels than rural participants. We found no significant 
differences in rural versus urban bacteria abundance using Wilcoxon signed-rank test.    
Bacteria 
 In all 40 subjects, the Firmicutes and Bacteroidetes phyla were dominant in the fecal 
samples, consisting of greater than 90% of total bacteria abundance. (Table 2)  
Regression Model 
 Using distinct linear models of bacteria (log10) = HbA1c status (normal or elevated), we 
found differences in bacteria abundance between normal and elevated HbA1c level subjects 
(Table 3). The differences in Firmicutes phylum and ratio between Firmicutes and Bacteroidetes 
coefficients were statistically significant in normal and elevated HbA1c individuals. Firmicutes, 
Actinobacteria, and the ratio abundances were negatively associated with elevated HbA1c while 
Bacteroidetes and Proteobacteria abundances were positively associated with elevated HbA1c. 
Only Firmicutes had a power value over 0.80, and all other models were underpowered at this 
small sample size. Power was found by two sample t-test of bacteria by normal/elevated HbA1c. 
Sample sizes necessary for 0.80 power for the given coefficients and standard deviations were 
also found. At least 350 people (175 rural, 175 urban) would be necessary for all models to have 
0.80 power. 
Effect Modifier 
 Rural urban status as an effect modifier was tested using interaction terms in the models 
of bacteria (log10) = HbA1c status (normal or elevated) + Rural/Urban status (rural or urban) + 
HbA1c status * Rural/Urban status (interaction term) (Table 4). We made four comparisons:  
normal HbA1c and rural, elevated HbA1c and rural, normal HbA1c and urban, and elevated 
HbA1c and urban. All interaction terms were found to be not significant. The interaction term 
was removed from the model and rural/urban was looked at together instead of by stratifying. 
Confounding 
 Rural/urban status as a confounder (Figure 1) was tested using the models of bacteria 
(log10) = HbA1c status (normal or elevated) + Rural/Urban status (rural or urban) (Table 5). The 
coefficient for change in HbA1c status was measured and compared to the previous models not 
controlling for rural/urban status. The percent change of all models exceeded 10%.  
 
Discussion 
We compared bacteria abundance by HbA1c levels of 20 rural and 20 urban subjects 
from the Hunan province of China. Urban subjects were found to have significantly higher 
insulin, waist circumference, BMI, and HbA1c. Firmicutes and Bacteroidetes were the most 
prominent phyla in the fecal samples, 49.60% and 46.33% respectively, while Proteobacteria, 
3.85%, and Actinobacteria, 0.18%, made up a smaller proportion. We found that participants 
with elevated HbA1c had lower abundances of Firmicutes, Actinobacteria, and ratio of 
Firmicutes to Bacteroidetes but higher abundances of Bacteroidetes and Proteobacteria compared 
to normal HbA1c level individuals. Rural/urban status as an interaction term with HbA1c status 
was found to be statistically insignificant. Controlling for rural/urban status changed coefficient 
for change in HbA1c status greater than 10%, indicating confounding [21]. 
These findings support previous research on gut microbiome and diabetes. Our Chinese 
subjects had similar pattern of higher BMI in urban participants as another study using data from 
the China Health and Nutrition Survey [22]. In line with our findings, Frank et al. similarly found 
that Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria dominated gut bacteria in 190 
gastrointestinal tissue samples. The abundance differences in elevated HbA1c subjects in 
Firmicutes, Bacteroidetes, Proteobacteria, and the ratio between Firmicutes and Bacteroidetes 
that we found were consistent with a study of 36 Danish men examining phyla abundances in 
adult type 2 diabetics versus nondiabetics [17, 24]. However, we found lower abundances of 
Actinobacteria in our elevated HbA1c subjects when the Danish study found no difference in 
diabetics versus nondiabetics [17].  
 Controlling for rural/urban status, we found that the percent change in the point estimate 
of HbA1c levels all exceeded 10%. This indicates that rural/urban status acts as a confounder 
because controlling for it significantly changes the relationship between bacteria abundance and 
change in HbA1c levels. We would expect rural/urban status to act as a confounder because diet, 
physical activity, and other lifestyle factors are associated with HbA1c as well as microbiota [25]. 
Using an interaction term, we did not find rural/urban status to be statistically significant as an 
effect modifier, but larger sample size studies may help confirm this as we were underpowered in 
this pilot study. Establishing the validity of the hypothesis that urbanization of the microbiome 
increases disease risk will require long-term, greater studies in larger samples. Because our study 
did not examine smaller taxonomies abundance differences or the diversity of the gut microbiota, 
further research is required to understand the results of this analysis. 
Conclusion 
 This study on 40 subjects examined associations between abundance of microbiota with 
HbA1c in urban versus rural individuals living in Hunan province, China. Firmicutes and 
Bacteroidetes were the dominant phyla in both urban and rural participants. The abundance of 
Firmicutes, Actinobacteria, and the ratio of Firmicutes to Bacteroidetes was lower while the 
abundance of Bacteroidetes and Proteobacteria were higher in elevated HbA1c level subjects 
than normal HbA1c level subjects. Rural/urban status was found to act as a confounder instead of 
an effect modifier; however our models of Bacteroidetes, Proteobacteria, Actinobacteria, and 
ratio of Firmicutes to Bacteroidetes were underpowered in our exploratory analysis and should 
be confirmed in larger samples. How rural/urban status acts to affect the microbiome, whether 
because of differences in diet, physical activity, or clustering are also in need of further research. 
Our results suggest a hypothesis that a difference in HbA1c levels is associated with differences 
in the microbiome after adjusting for urban/rural status as a confounder. These exploratory 
findings may help to understand differences in the microbiome between rural and urban subjects 
that can be attributed to HbA1c levels. 
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Tables and Figures 
Table 1. Characteristics of participants from Hunan China stratified by rural and urban status 
  Rural Urban P-value 
Subject Characteristics       
Total number subjects 20 20   
Number (%) female 5 (25%) 13 (65%)   
Mean (std) Age Range 50.6 (11.7) 58.8 (10.7)   
Significant Differences in Metadata       
Insulin (µU/mL) 4.3 9.8 <0.0001 
Waist circumference (cm) 73.8 85.2 0.0003 
BMI (kg/m2) 21.1 24.4 0.0005 
HbA1c (%) 5.7 6.6 0.0013 
Bacteriaa       
Firmicutes 4.69 4.64 0.37 
Bacteroidetes 4.64 4.65 0.59 
Proteobacteria 3.43 3.7 0.15 
Actinobacteria 2.34 2.12 0.36 
Ratio 1.01 1 0.81 
aLog10 normalized abundance 
bRatio = Firmicutes / Bacteroidetes 
 
Table 2. Mean abundance (log10) of potential bacteria related to diabetes and relative proportion 
of gut bacteria 
Bacteriaa Mean Stdb Proportion 
Firmicutes 4.67 0.13 49.60% 
Bacteroidetes 4.64 0.14 46.33% 
Proteobacteria 3.56 0.46 3.85% 
Actinobacteria 2.23 0.6 0.18% 
Ratioc 1 0.056 - 
 aLog10 normalized abundance 
bStandard devation 
cRatio = Firmicutes / Bacteroidetes 
Table 3. Difference in log10 bacteria abundance in normal versus elevated HbA1c levels and 
sample size necessary for 0.80 power in each model 
Bacteriaa Coefficient Stdb P-value Power Sample Size Needed 
Firmicutes -0.11 0.039 0.008* 0.82 40 
Bacteroidetes 0.062 0.044 0.177 0.26 172 
Proteobacteria 0.23 0.15 0.122 0.36 120 
Actinobacteria -0.18 0.19 0.367 0.15 350 
Ratioc -0.037 0.017 0.034 0.58 68 
aModel: Bacteria (log10) = HbA1c status (normal or elevated) 
bStandard devation 
cRatio = Firmicutes / Bacteroidetes 
*Adequate power 
 
Table 4. Expected log10 bacteria abundance including interaction term for HbA1c status and 
rural/urban status in 4 comparisons 
Bacteriaa 
Rural + 
Normal 
Rural + 
Elevated 
Urban + 
Normal 
Urban + 
Elevated P-value 
Firmicutes 4.71 4.64 4.73 4.59 0.52 
Bacteroidetes 4.62 4.65 4.61 4.72 0.54 
Proteobacteria 3.83 3.68 3.36 3.57 0.39 
Actinobacteria 1.88 2.14 2.40 2.19 0.39 
Ratio 1.02 1.00 1.03 0.97 0.51 
 aModel: Bacteria (log10) = HbA1c status (normal or elevated) + Rural/Urban status (rural or 
urban) + HbA1c status * Rural/Urban status  
 
 
 
 
 
 Table 5. Change in coefficients for log10 bacteria abundance with and without control for 
rural/urban status 
Bacteriaa 
Coefficient for Change in HbA1c 
status not controlling for 
rural/urban 
Coefficient for Change in 
HbA1c status controlling for  
rural/urban Change (%) 
Firmicutes -0.11 -0.13 15 
Bacteroidetes 0.062 0.088 42 
Proteobacteria 0.23 0.101 56 
Actinobacteria -0.18 -0.06 65 
Ratio -0.037 -0.05 24 
aModel: Bacteria (log10) = HbA1c status (normal or elevated) + Rural/Urban status (rural or 
urban) 
 
Figure 1. Rural and urban as potential confounder to gut microbiome and HbA1c 
 
